Glucocorticoid Sensitivity Among Young Survivors of Childhood Acute Lymphoblastic Leukemia: What Does It Matter?

Author:

Siviero-Miachon Adriana AparecidaORCID,de Sousa AnaVirgínia Lopes1,Simião Bruno Moreira2,Araújo Elisangela Oliveira3,Alvarenga Renato3,Spinola-Castro Angela MariaORCID,Longui Carlos Alberto3ORCID

Affiliation:

1. Pediatric Oncology, Hospital of the Support Group for Adolescent and Children with Cancer – GRAACC, Sao Paulo, Brazil

2. Pediatric Endocrinology, Federal University of Sao Paulo – UNIFESP/EPM, Sao Paulo, Brazil

3. Physiological Sciences, Faculty of Medical Sciences of Santa Casa de Sao Paulo – FCM SCSP, Sao Paulo, Brazil

Abstract

AbstractThe aim of the study was to assess glucocorticoid sensitivity in survivors of childhood acute lymphoblastic leukemia using in vivo and in vitro tests. Thirty leukemia survivors of both sexes aged ≥18 years participated in the study and at least two years after therapy withdrawal. In vivo tests comprised: a) a very low dose intravenous dexamethasone suppression test for measurement of serum cortisol before, after, and % suppression, compared with 32 age-matched controls; and b) 0.25 mg overnight oral dexamethasone suppression test for assessment of salivary cortisol before, after, and % suppression. In vitro methods comprised: c) glucocorticoid receptor polymorphisms: BcI1-NR3C1 and A3669G; and d) splicing variant of glucocorticoid receptor GR-α mRNA by real-time quantitative polymerase chain reaction, compared with 32 controls. There was a reduction in salivary cortisol, and 73.3% of leukemia survivors showed high sensitivity according to % suppression after oral dexamethasone (p<0.05). Serum cortisol at baseline, after the test, % suppression after intravenous dexamethasone, and the percentage of high sensitivity were reduced in the leukemia group (%F=36.7; p<0.05). The BcI1-NR3C1 and A3669G polymorphisms were present in 11/30 (36.7%) and 5/30 (16.7%) patients, respectively. GR-α mRNA levels were lower in the leukemia group than in the controls (p<0.05). Survivors of acute lymphoblastic leukemia presented with reduced glucocorticoid sensitivity. Glucocorticoid sensitivity allows individualized treatment to avoid adverse effects and may be involved in cardiovascular disease risk among this particular group of cancer survivors.

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Georg Thieme Verlag KG

Reference40 articles.

1. Evaluation of glucocorticoid sensitivity and its potential clinical applicability;C A Longui;Horm Res,2009

2. Glucocorticoid sensitivity in health and disease;R A Quax;Nat Rev Endocrinol,2013

3. Molecular mechanisms regulating glucocorticoid sensitivity and resistance;K L Gross;Mol Cell Endocrinol,2009

4. Corticosteroids: mechanisms of action in health and disease;S Ramamoorthy;Rheum Dis Clin North Am,2016

5. Glucocorticoid resistance: interference between the glucocorticoid receptor and the MAPK Signalling pathways;L M Sevilla;Int J Mol Sci,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3